Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
277,563,973
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
59,797,491
-
Shares change
-
-2,182,088
-
Total reported value, excl. options
-
$89,693,906
-
Value change
-
-$5,899,472
-
Put/Call ratio
-
142%
-
Number of buys
-
41
-
Number of sells
-
-29
-
Price
-
$1.50
Significant Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q4 2022
93 filings reported holding IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share as of Q4 2022.
Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,797,491 shares
of 277,563,973 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include FMR LLC (14,110,982 shares), M28 Capital Management LP (9,248,250 shares), Alphabet Inc. (5,680,785 shares), ORBIMED ADVISORS LLC (5,270,400 shares), BlackRock Inc. (3,877,043 shares), Slate Path Capital LP (3,735,000 shares), 683 Capital Management, LLC (3,000,000 shares), VANGUARD GROUP INC (2,691,919 shares), Bain Capital Life Sciences Investors, LLC (1,937,207 shares), and Redmile Group, LLC (1,440,725 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.